Annual Shareholders Equity
-$8.44 M
-$8.33 M-7813.51%
December 31, 2022
Summary
- As of February 8, 2025, NAVB annual stockholders equity is -$8.44 million, with the most recent change of -$8.33 million (-7813.51%) on December 31, 2022.
- During the last 3 years, NAVB annual shareholders equity has fallen by -$6.82 million (-423.22%).
- NAVB annual shareholders equity is now -115.25% below its all-time high of $55.30 million, reached on December 31, 1996.
Performance
NAVB Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
-$3.27 M
-$2.19 M-203.27%
September 30, 2023
Summary
- As of February 8, 2025, NAVB quarterly stockholders equity is -$3.27 million, with the most recent change of -$2.19 million (-203.27%) on September 30, 2023.
- Over the past year, NAVB quarterly shareholders equity has dropped by -$2.19 million (-203.27%).
- NAVB quarterly shareholders equity is now -105.92% below its all-time high of $55.30 million, reached on December 31, 1996.
Performance
NAVB Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
NAVB Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -7813.5% | -203.3% |
| 3 y3 years | -423.2% | -203.3% |
| 5 y5 years | -174.1% | -203.3% |
NAVB Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -7813.5% | at low | -2970.0% | +66.7% |
| 5 y | 5-year | -741.2% | at low | -157.4% | +66.7% |
| alltime | all time | -115.3% | +87.6% | -105.9% | +95.2% |
Navidea Biopharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | -$3.27 M(+203.3%) |
| Jun 2023 | - | -$1.08 M(-89.0%) |
| Mar 2023 | - | -$9.84 M(+16.6%) |
| Dec 2022 | -$8.44 M(+7813.5%) | -$8.44 M(+70.1%) |
| Sep 2022 | - | -$4.96 M(+9.4%) |
| Jun 2022 | - | -$4.53 M(+88.7%) |
| Mar 2022 | - | -$2.40 M(+2153.3%) |
| Dec 2021 | -$106.60 K(-108.1%) | -$106.60 K(-103.1%) |
| Sep 2021 | - | $3.40 M(-40.4%) |
| Jun 2021 | - | $5.70 M(+33.4%) |
| Mar 2021 | - | $4.28 M(+225.1%) |
| Dec 2020 | $1.32 M(-181.6%) | $1.32 M(+674.3%) |
| Sep 2020 | - | $169.90 K(-107.2%) |
| Jun 2020 | - | -$2.35 M(+29.2%) |
| Mar 2020 | - | -$1.82 M(+13.0%) |
| Dec 2019 | -$1.61 M(-192.5%) | -$1.61 M(+111.9%) |
| Sep 2019 | - | -$761.00 K(-133.6%) |
| Jun 2019 | - | $2.26 M(-494.5%) |
| Mar 2019 | - | -$573.70 K(-132.9%) |
| Dec 2018 | $1.74 M(-84.7%) | $1.74 M(+29.8%) |
| Sep 2018 | - | $1.34 M(-36.7%) |
| Jun 2018 | - | $2.12 M(-50.5%) |
| Mar 2018 | - | $4.28 M(-62.4%) |
| Dec 2017 | $11.38 M(-116.7%) | $11.38 M(-25.8%) |
| Sep 2017 | - | $15.35 M(-8.0%) |
| Jun 2017 | - | $16.67 M(-23.2%) |
| Mar 2017 | - | $21.70 M(-131.8%) |
| Dec 2016 | -$68.14 M(+25.5%) | -$68.14 M(+6.1%) |
| Sep 2016 | - | -$64.24 M(-0.2%) |
| Jun 2016 | - | -$64.38 M(+11.7%) |
| Mar 2016 | - | -$57.63 M(+6.1%) |
| Dec 2015 | -$54.31 M(+82.2%) | -$54.31 M(+3.9%) |
| Sep 2015 | - | -$52.29 M(+16.0%) |
| Jun 2015 | - | -$45.09 M(+25.8%) |
| Mar 2015 | - | -$35.85 M(+20.3%) |
| Dec 2014 | -$29.80 M(+643.3%) | -$29.80 M(-4.7%) |
| Sep 2014 | - | -$31.26 M(+31.2%) |
| Jun 2014 | - | -$23.84 M(+63.2%) |
| Mar 2014 | - | -$14.61 M(+264.3%) |
| Dec 2013 | -$4.01 M(+185.3%) | -$4.01 M(-145.2%) |
| Sep 2013 | - | $8.86 M(-583.6%) |
| Jun 2013 | - | -$1.83 M(-32.6%) |
| Mar 2013 | - | -$2.72 M(+93.5%) |
| Dec 2012 | -$1.41 M(-106.7%) | -$1.41 M(-151.0%) |
| Sep 2012 | - | $2.75 M(-72.3%) |
| Jun 2012 | - | $9.93 M(-32.5%) |
| Mar 2012 | - | $14.71 M(-30.4%) |
| Dec 2011 | $21.13 M(+411.5%) | $21.13 M(-25.8%) |
| Sep 2011 | - | $28.48 M(+368.6%) |
| Jun 2011 | - | $6.08 M(-28.4%) |
| Mar 2011 | - | $8.49 M(+105.4%) |
| Dec 2010 | $4.13 M(-141.9%) | $4.13 M(+270.3%) |
| Sep 2010 | - | $1.12 M(-58.7%) |
| Jun 2010 | - | $2.70 M(-124.5%) |
| Mar 2010 | - | -$11.04 M(+11.9%) |
| Dec 2009 | -$9.87 M(+226.2%) | -$9.87 M(-5.0%) |
| Sep 2009 | - | -$10.39 M(-64.4%) |
| Jun 2009 | - | -$29.21 M(+94.0%) |
| Mar 2009 | - | -$15.06 M(+397.7%) |
| Dec 2008 | -$3.03 M | -$3.03 M(+76.4%) |
| Sep 2008 | - | -$1.72 M(+1533.5%) |
| Jun 2008 | - | -$105.00 K(-94.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2008 | - | -$1.85 M(-53.0%) |
| Dec 2007 | -$3.94 M(+1223.4%) | -$3.94 M(+88.9%) |
| Sep 2007 | - | -$2.09 M(+5.3%) |
| Jun 2007 | - | -$1.98 M(+47.5%) |
| Mar 2007 | - | -$1.34 M(+351.2%) |
| Dec 2006 | -$298.00 K(-107.4%) | -$298.00 K(-138.5%) |
| Sep 2006 | - | $774.80 K(-67.6%) |
| Jun 2006 | - | $2.39 M(-25.1%) |
| Mar 2006 | - | $3.19 M(-20.5%) |
| Dec 2005 | $4.02 M(-34.8%) | $4.02 M(-24.3%) |
| Sep 2005 | - | $5.31 M(-19.2%) |
| Jun 2005 | - | $6.57 M(-17.0%) |
| Mar 2005 | - | $7.92 M(+28.5%) |
| Dec 2004 | $6.16 M(+17.2%) | $6.16 M(-11.1%) |
| Sep 2004 | - | $6.93 M(-2.6%) |
| Jun 2004 | - | $7.11 M(-0.4%) |
| Mar 2004 | - | $7.14 M(+35.7%) |
| Dec 2003 | $5.26 M(+32.8%) | $5.26 M(+55.9%) |
| Sep 2003 | - | $3.37 M(-12.2%) |
| Jun 2003 | - | $3.84 M(+0.8%) |
| Mar 2003 | - | $3.81 M(-3.8%) |
| Dec 2002 | $3.96 M(-42.6%) | $3.96 M(-4.4%) |
| Sep 2002 | - | $4.14 M(-20.6%) |
| Jun 2002 | - | $5.22 M(-13.9%) |
| Mar 2002 | - | $6.06 M(-12.2%) |
| Dec 2001 | $6.90 M(+132.8%) | $6.90 M(+89.7%) |
| Sep 2001 | - | $3.64 M(+12.8%) |
| Jun 2001 | - | $3.22 M(+5.8%) |
| Mar 2001 | - | $3.05 M(+2.8%) |
| Dec 2000 | $2.97 M(-2233.5%) | $2.97 M(+32.3%) |
| Sep 2000 | - | $2.24 M(+29.3%) |
| Jun 2000 | - | $1.73 M(+55.8%) |
| Mar 2000 | - | $1.11 M(-77.7%) |
| Dec 1999 | -$139.00 K(-102.9%) | - |
| Jun 1999 | - | $5.00 M(-20.6%) |
| Mar 1999 | - | $6.30 M(+30.6%) |
| Dec 1998 | $4.83 M(-85.2%) | $4.83 M(-67.4%) |
| Sep 1998 | - | $14.80 M(-27.5%) |
| Jun 1998 | - | $20.40 M(-20.3%) |
| Mar 1998 | - | $25.60 M(-21.4%) |
| Dec 1997 | $32.55 M(-41.1%) | $32.55 M(-15.4%) |
| Sep 1997 | - | $38.50 M(-12.1%) |
| Jun 1997 | - | $43.80 M(-14.1%) |
| Mar 1997 | - | $51.00 M(-7.8%) |
| Dec 1996 | $55.30 M(+176.5%) | $55.30 M(+14.0%) |
| Sep 1996 | - | $48.50 M(-3.4%) |
| Jun 1996 | - | $50.20 M(+146.1%) |
| Mar 1996 | - | $20.40 M(+2.0%) |
| Dec 1995 | $20.00 M(0.0%) | $20.00 M(-2.0%) |
| Sep 1995 | - | $20.40 M(+24.4%) |
| Jun 1995 | - | $16.40 M(+86.4%) |
| Mar 1995 | - | $8.80 M(-56.0%) |
| Dec 1994 | $20.00 M(+83.5%) | $20.00 M(+150.0%) |
| Sep 1994 | - | $8.00 M(+15.9%) |
| Jun 1994 | - | $6.90 M(-22.5%) |
| Mar 1994 | - | $8.90 M(-18.3%) |
| Dec 1993 | $10.90 M(-12.1%) | $10.90 M(+58.0%) |
| Sep 1993 | - | $6.90 M(-24.2%) |
| Jun 1993 | - | $9.10 M(-17.3%) |
| Mar 1993 | - | $11.00 M(-11.3%) |
| Dec 1992 | $12.40 M | $12.40 M(+148.0%) |
| Sep 1992 | - | $5.00 M |
FAQ
- What is Navidea Biopharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Navidea Biopharmaceuticals?
- What is Navidea Biopharmaceuticals annual shareholders equity year-on-year change?
- What is Navidea Biopharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Navidea Biopharmaceuticals?
- What is Navidea Biopharmaceuticals quarterly shareholders equity year-on-year change?
What is Navidea Biopharmaceuticals annual stockholders equity?
The current annual shareholders equity of NAVB is -$8.44 M
What is the all time high annual shareholders equity for Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals all-time high annual stockholders equity is $55.30 M
What is Navidea Biopharmaceuticals annual shareholders equity year-on-year change?
Over the past year, NAVB annual stockholders equity has changed by -$8.33 M (-7813.51%)
What is Navidea Biopharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of NAVB is -$3.27 M
What is the all time high quarterly shareholders equity for Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals all-time high quarterly stockholders equity is $55.30 M
What is Navidea Biopharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, NAVB quarterly stockholders equity has changed by -$2.19 M (-203.27%)